$CRSP CRISPR Therapeutics AG Insider Trading Week 35/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CRISPR Therapeutics AG in week 35/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | M | 59.31 | 15,000 | 889,650 | 15,000 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | M | 13.62 | 15,000 | 204,300 | 15,000 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | M | 14.00 | 30,000 | 420,000 | 30,000 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 93.74 | 200 | 18,748 | 0 | 200 to 0 (-100.00 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 92.98 | 19,135 | 1,779,256 | 200 | 19.3 K to 200 (-98.97 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 92.40 | 36,365 | 3,360,162 | 19,335 | 55.7 K to 19.3 K (-65.29 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 91.27 | 4,300 | 392,477 | 55,700 | 60 K to 55.7 K (-7.17 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | M | 59.31 | 15,000 | 889,650 | 60,000 | 45 K to 60 K (+33.33 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | M | 13.62 | 15,000 | 204,300 | 45,000 | 30 K to 45 K (+50.00 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | M | 14.00 | 30,000 | 420,000 | 30,000 | 0 to 30 K |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | M | 17.75 | 12,000 | 213,000 | 156,000 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 93.18 | 2,800 | 260,904 | 410 | 3.2 K to 410 (-87.23 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 92.23 | 6,400 | 590,272 | 3,210 | 9.6 K to 3.2 K (-66.60 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 91.39 | 2,800 | 255,892 | 9,610 | 12.4 K to 9.6 K (-22.56 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Buy | M | 17.75 | 12,000 | 213,000 | 12,410 | 410 to 12.4 K (+2,926.83 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | M | 17.75 | 12,000 | 213,000 | 156,000 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 93.18 | 2,800 | 260,904 | 410 | 3.2 K to 410 (-87.23 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 92.23 | 6,400 | 590,272 | 3,210 | 9.6 K to 3.2 K (-66.60 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 91.39 | 2,800 | 255,892 | 9,610 | 12.4 K to 9.6 K (-22.56 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Buy | M | 17.75 | 12,000 | 213,000 | 12,410 | 410 to 12.4 K (+2,926.83 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.43 | 21,067 | 303,997 | 215,315 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.00 | 3,933 | 55,062 | 111,893 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 93.19 | 3,840 | 357,850 | 648,007 | 651.8 K to 648 K (-0.59 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 92.59 | 19,754 | 1,829,023 | 651,847 | 671.6 K to 651.8 K (-2.94 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 91.54 | 1,406 | 128,705 | 671,601 | 673 K to 671.6 K (-0.21 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.43 | 21,067 | 303,997 | 673,007 | 651.9 K to 673 K (+3.23 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.00 | 3,933 | 55,062 | 651,940 | 648 K to 651.9 K (+0.61 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.43 | 21,067 | 303,997 | 215,315 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Option Exercise | M | 14.00 | 3,933 | 55,062 | 111,893 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 93.19 | 3,840 | 357,850 | 648,007 | 651.8 K to 648 K (-0.59 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 92.59 | 19,754 | 1,829,023 | 651,847 | 671.6 K to 651.8 K (-2.94 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Sell | S | 91.54 | 1,406 | 128,705 | 671,601 | 673 K to 671.6 K (-0.21 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.43 | 21,067 | 303,997 | 673,007 | 651.9 K to 673 K (+3.23 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Novak Rodger | President | Buy | M | 14.00 | 3,933 | 55,062 | 651,940 | 648 K to 651.9 K (+0.61 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Payment of Exercise | F | 94.15 | 779 | 73,343 | 169,968 | 170.7 K to 170 K (-0.46 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Payment of Exercise | F | 94.15 | 779 | 73,343 | 169,968 | 170.7 K to 170 K (-0.46 %) |